Biofourmis

ActiveBorn in Singapore, based elsewhere

Remote patient monitoring · Singapore

HQFounded in Singapore in 2015; HQ in Boston since its 2024 merger with CopilotIQ

Last roundFunding round · Oct 2024

Country of originSingaporeBorn here, based elsewhere

BasedFounded in Singapore in 2015; HQ in Boston since its 2024 merger with CopilotIQ

Born in Singapore, based elsewhere

Biofourmis is listed by the Singapore ranking as a company founded by Singapore-linked founders but headquartered abroad: it is not ranked in Singapore. Founded in Singapore in 2015; HQ in Boston since its 2024 merger with CopilotIQ.

Funding history

Date	Round	Amount	Type	Investors
Oct 2024	Funding round	about USD 100M	—	General Atlantic, Openspace, Bessemer Venture Partners

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Uback rankings

How the AI ranks →

Ranking	Tier	Rank	Edition	Next update
Singapore · all sectors	Born here, based elsewhere	—	Edition 0 · October 2026	2 Nov 2026

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Biofourmis as a PDF. It must answer at least one of these four questions, and stick to them:

ValuationWhat is Biofourmis worth?

Versus competitorsHow does it compare?

Who should acquire itStrategic buyers, and why

Who should it acquireAcquisition targets, and why

Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Invest

Back Biofourmis whether or not it has agreed: your intention joins the pool on Biofourmis, passed to the Fundraising Desk of its country once it reaches critical mass. Backing on Uback (pronounced “you back”) means declaring an Interest (free) or an Intention (coming soon). Backing does not mean that this company is raising funds or that a shareholder is selling shares, and it is not a commitment to invest. Any deal, through a funding round or a sale by an existing shareholder, is handled by a partner desk: the Fundraising Desk of the country for a round, the Secondary Sales Desk assigned to the company for a sale.

Back Biofourmis Or back healthtech in Singapore

Pool on BiofourmisBelow threshold

BackersBelow threshold

Paid intention · valid for life · movable until you sign with a partner desk. If the company does not follow up, Uback invites its Backers to move their intentions to a competitor or a similar company. Investing in non-listed companies carries a risk of losing all the capital invested.

Do you run Biofourmis?

Claim this profile to correct data, add your logo and description, or tell Uback about an upcoming round.

Claim this profile Report an upcoming round → Report an error →

Are you a shareholder?

Considering selling some of your shares? Tell Uback privately. Nothing is published without your consent, and never a price or a volume.

Tell Uback privately

What the AI reads

Read by the AI at the next edition.

Comparable companies in Singapore

Full Singapore ranking →

OKX#1Crypto › exchangeDecacorn Crypto.com#2Crypto › exchange & appDecacorn Airwallex#3Fintech › cross-border paymentsDecacorn KuCoin#4Crypto › exchangeUnicorn

Last updated: Oct 2026Report an error

Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.